XenoPort Provides Highlights of HORIZANT Prescription Trends and Update on Development for Alcohol Use Disorder | Sunday, January 11, 2015 12:00 PM |
[Business Wire] - XenoPort today reported an update on prescription trends and further development of HORIZANT® Extended-Release Tablets, including feedback from the U.S.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.